Czech biotech Sotio aims to become a leading oncology specialty pharma company by growingits portfolio through collaborations, in-licensing, minority investments and/or M&As. Before using Cortellis Deals Intelligence™, Jakub Jarolim, a competitive intelligence professional at Sotio, could not find accurate and detailed comparable deals data.
